Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial - Wikidata - awgldk - TriplyDB

Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial

Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial

http://www.wikidata.org/entity/Q34170485

about

Anti-vascular endothelial growth factor for diabetic macular oedema Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema Modern retinal laser therapy Agent-based model of angiogenesis simulates capillary sprout initiation in multicellular networks.Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy New Therapeutic Approaches in Diabetic Retinopathy.Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.Choosing preclinical study models of diabetic retinopathy: key problems for consideration Anti-VEGF for the management of diabetic macular edema.A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study).Recent advancements in diabetic retinopathy treatment from the Diabetic Retinopathy Clinical Research Network Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial.Topical nonsteroidal anti-inflammatory drugs for macular edema.Diabetic Retinopathy and Diabetic Macular Edema.Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients.Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy.Agent-based computational model of retinal angiogenesis simulates microvascular network morphology as a function of pericyte coverage.Recent advances in the management and understanding of diabetic retinopathy.Management of diabetic macular edema in Japan: a review and expert opinion.Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop.

P2860

Q24193083-C5153D15-1AE4-4B3B-9FB6-F2858B788047 Q26786012-75C78042-88E8-440D-925C-9F55890FB388 Q26823096-513090A7-A8B9-4E8C-843B-534C7C89972E Q27334865-DD809F6D-2A86-4FE3-8EBA-C874A057288A Q28262797-970A66B3-C831-4164-8198-08AC7B43594E Q33583037-CF596734-1E75-4C2A-986A-3C385CAFC259 Q34558187-FCC54941-008C-47D9-B900-C430299A2FD5 Q34564352-EE6E67DD-6591-4D2E-95F0-5DD4AC879F61 Q35151008-43123487-0F63-4E55-B281-FD318D7EEDD3 Q35809696-8AAAD464-61AD-411D-9FDB-4F01068254A8 Q35935370-A4F35029-085D-4DDE-8BE0-C1655D205699 Q36155647-7A7C41B1-FC6A-441B-9091-A79B265CEFE2 Q38162433-F493BDBF-8D56-41F4-AFE4-37DAE0C3D84C Q38616344-1BF183D4-BE76-4B9C-82F1-EB9B267FF362 Q38650949-614F78DE-19CA-421D-99E1-82815901B34B Q38817006-640A32D2-D791-47A6-BE9F-DD2FE491D83C Q40979686-E875BDF7-8C2F-405E-8DC8-BB29D9F01115 Q41498626-32F0CB27-E107-4879-A4BB-E84D7341B544 Q45065026-41D73567-A1F6-4B91-89B9-A1D15314BCE4 Q47168388-3EB61B5E-161A-48BE-A1CB-14A4CE937A40 Q48579709-823BF17C-2C58-41BE-8C6C-E4E544A0A2BE Q55312812-C2F1D4C8-5F2F-4FFE-B1FC-65973020AD22

P2860

Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial

http://www.wikidata.org/entity/Q34170485

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Exploratory analysis of the ef ...... in a randomized clinical trial

@ast

Exploratory analysis of the ef ...... in a randomized clinical trial

@en

Exploratory analysis of the ef ...... in a randomized clinical trial

@nl

type

label

Exploratory analysis of the ef ...... in a randomized clinical trial

@ast

Exploratory analysis of the ef ...... in a randomized clinical trial

@en

Exploratory analysis of the ef ...... in a randomized clinical trial

@nl

prefLabel

Exploratory analysis of the ef ...... in a randomized clinical trial

@ast

Exploratory analysis of the ef ...... in a randomized clinical trial

@en

Exploratory analysis of the ef ...... in a randomized clinical trial

@nl

P1433

Q34170485-697157FE-C2F7-4C42-BB0F-05C3EF04ADB6

P1476

Q34170485-42E64701-5275-4475-8C85-0BA590B3FE23

P2093

Q34170485-14E43ACD-6DBB-4BB4-B3B6-BA8A4B5EE360

Q34170485-6F6AEC53-5A95-4BD9-89DC-81414E5D189E

Q34170485-7C001160-9000-4C5F-A20E-8A0F1D710E2F

Q34170485-887F3FB8-63B6-4ABB-B6E7-877DD27E497A

Q34170485-9B3F38B6-49F3-4B4A-B4BA-1178CE1B1DE4

Q34170485-AEC94F75-C10D-47D5-80F6-47303FB356E7

Q34170485-C1E89145-F4D5-4D79-95A8-A84374BAC85A

Q34170485-D31CB466-CAE3-4EC7-AFAE-2F4B84DCFCC9

Q34170485-FD12C7D0-8EB4-4BB4-AC17-73C8917408F2

P2860

Q34170485-19258C87-7300-41E9-B82E-79F62BB42CC9

Q34170485-2E6D5AA1-98A3-428D-B327-28CFCFFFAD30

Q34170485-3859B8A1-DCF0-4196-B263-B9EA2025BA0E

Q34170485-50598644-F1A5-4D9D-89FC-7EF3C690410D

Q34170485-5F963740-F213-467E-A0BC-A1F102B61EC6

Q34170485-605CB6C3-76C3-49C8-9635-023AC1DA39B6

Q34170485-6484E83D-658D-470A-BC1B-D0EB4BF7EDED

Q34170485-857DD3E3-7B61-4142-BF25-B6362B670780

Q34170485-8D5D58BA-EDA4-4FF5-9E2E-02657C9852F3

Q34170485-94C71511-B8C9-4DF5-9615-6267D30256B3

P304

Q34170485-37D0B36B-69B7-4BCB-B6F6-4EA0DBFCD07B

P31

Q34170485-77454486-C74D-46E3-A30D-64571A08EB9F

P356

Q34170485-667D6252-8495-4320-9812-E8B2F1EB0212

P407

Q34170485-63C818ED-530F-49C0-94F5-BC2E41D9F04D

P433

Q34170485-66DC66BA-4B92-4189-9058-54F23F4831CA

P478

Q34170485-AECD5D73-1467-4748-B7B4-21F37A6E22E2

P577

Q34170485-CAC738CC-25D8-445B-BBF1-2843655C2148

P698

Q34170485-D1059711-FDE3-4F3C-8BF4-8F3DD8D6E5A3

P932

Q34170485-716B1BCE-315C-4AAA-885C-8A7F58FAE918

P356

JAMAOPHTHALMOL.2013.4154

P1433

JAMA Ophthalmology

P1476

Exploratory analysis of the ef ...... in a randomized clinical trial

@en

P2093

Clement K Chan

http://www.w3.org/2001/XMLSchema#string

David G Miller

http://www.w3.org/2001/XMLSchema#string

Diabetic Retinopathy Clinical Research Network

http://www.w3.org/2001/XMLSchema#string

Haijing Qin

http://www.w3.org/2001/XMLSchema#string

Michele Melia

http://www.w3.org/2001/XMLSchema#string

Neil M Bressler

http://www.w3.org/2001/XMLSchema#string

Roy W Beck

http://www.w3.org/2001/XMLSchema#string

Sandeep Grover

http://www.w3.org/2001/XMLSchema#string

Susan B Bressler

http://www.w3.org/2001/XMLSchema#string

P2860

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy.

Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Long-term effects of ranibizumab on diabetic retinopathy severity and progression.

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.

Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy.

A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

P304

1033-1040

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAOPHTHALMOL.2013.4154

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23807371

http://www.w3.org/2001/XMLSchema#string

P932

4162127

http://www.w3.org/2001/XMLSchema#string